RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.270
-0.010 (-0.78%)
At close: Sep 15, 2025, 4:00 PM EDT
1.270
0.00 (0.00%)
After-hours: Sep 15, 2025, 6:47 PM EDT

RenovoRx Statistics

Total Valuation

RenovoRx has a market cap or net worth of $46.54 million. The enterprise value is $35.04 million.

Market Cap46.54M
Enterprise Value 35.04M

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025, before market open.

Earnings Date Nov 12, 2025
Ex-Dividend Date n/a

Share Statistics

RenovoRx has 36.65 million shares outstanding. The number of shares has increased by 95.52% in one year.

Current Share Class 36.65M
Shares Outstanding 36.65M
Shares Change (YoY) +95.52%
Shares Change (QoQ) +16.50%
Owned by Insiders (%) 3.34%
Owned by Institutions (%) 9.61%
Float 30.08M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 57.08
Forward PS 17.21
PB Ratio 4.41
P/TBV Ratio 4.43
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 52.92
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.61, with a Debt / Equity ratio of 0.02.

Current Ratio 8.61
Quick Ratio 8.15
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -107.11% and return on invested capital (ROIC) is -69.70%.

Return on Equity (ROE) -107.11%
Return on Assets (ROA) -54.82%
Return on Invested Capital (ROIC) -69.70%
Return on Capital Employed (ROCE) -93.06%
Revenue Per Employee $66,200
Profits Per Employee -$1.07M
Employee Count10
Asset Turnover 0.05
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +8.79% in the last 52 weeks. The beta is 1.23, so RenovoRx's price volatility has been higher than the market average.

Beta (5Y) 1.23
52-Week Price Change +8.79%
50-Day Moving Average 1.17
200-Day Moving Average 1.18
Relative Strength Index (RSI) 56.75
Average Volume (20 Days) 579,524

Short Selling Information

The latest short interest is 198,095, so 0.54% of the outstanding shares have been sold short.

Short Interest 198,095
Short Previous Month 134,441
Short % of Shares Out 0.54%
Short % of Float 0.66%
Short Ratio (days to cover) 0.91

Income Statement

In the last 12 months, RenovoRx had revenue of $662,000 and -$10.66 million in losses. Loss per share was -$0.36.

Revenue662,000
Gross Profit 416,000
Operating Income -11.25M
Pretax Income -8.05M
Net Income -10.66M
EBITDA n/a
EBIT -11.25M
Loss Per Share -$0.36
Full Income Statement

Balance Sheet

The company has $12.31 million in cash and $260,000 in debt, giving a net cash position of $12.05 million or $0.33 per share.

Cash & Cash Equivalents 12.31M
Total Debt 260,000
Net Cash 12.05M
Net Cash Per Share $0.33
Equity (Book Value) 10.64M
Book Value Per Share 0.29
Working Capital 11.84M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$10.31 million and capital expenditures -$14,000, giving a free cash flow of -$10.32 million.

Operating Cash Flow -10.31M
Capital Expenditures -14,000
Free Cash Flow -10.32M
FCF Per Share -$0.28
Full Cash Flow Statement

Margins

Gross Margin 62.84%
Operating Margin -1,699.09%
Pretax Margin -1,610.88%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

RenovoRx does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -95.52%
Shareholder Yield -95.52%
Earnings Yield -22.65%
FCF Yield -21.92%

Analyst Forecast

The average price target for RenovoRx is $7.50, which is 490.55% higher than the current price. The consensus rating is "Strong Buy".

Price Target $7.50
Price Target Difference 490.55%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) 394.31%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

RenovoRx has an Altman Z-Score of -0.83 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.83
Piotroski F-Score 1